Drug profile · INN
sacrosidase
SUCRAID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sacrosidase (SUCRAID) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sacrosidase
Brand SUCRAID
Route ORAL
Formulation SOLUTION
Frequently asked questions
What is sacrosidase?
sacrosidase (SUCRAID) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sacrosidase?
SUCRAID is a marketed brand name for sacrosidase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sacrosidase?
sacrosidase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.